+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Biological Safety Cabinet Market by Type, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6011395
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Biological Safety Cabinet Market grew from USD 456.46 million in 2023 to USD 494.74 million in 2024. It is expected to continue growing at a CAGR of 8.47%, reaching USD 806.93 million by 2030.

A Biological Safety Cabinet (BSC) is a crucial containment device ensuring the safe handling of infectious agents and biohazardous materials in laboratory settings. These cabinets are essential for protecting researchers, samples, and the environment from contamination, primarily through highly efficient air filtration systems. The necessity for BSCs arises in laboratory environments where pathogenic microorganisms are cultured, demanding stringent control measures to avert exposure and contamination. BSCs are predominantly employed across pharmaceutical, biotechnological, and clinical diagnostics sectors, serving as an end-use scope. Increasing investment in healthcare infrastructure and a surge in infectious disease research are pivotal factors influencing market growth. Furthermore, the rising incidence of pandemics has spotlighted the indispensable role of BSCs, opening new opportunities in developing advanced safety cabinets with enhanced features like energy efficiency and digital monitoring. However, market growth faces challenges such as the high cost of equipment and stringent regulatory compliance associated with BSC usage. Further hurdles include complex maintenance requirements and end-user education. Innovation opportunities lie in the development of cost-effective, eco-friendly safety cabinets with real-time monitoring capabilities. Leveraging IoT and AI integration could enhance operational efficiency and enable predictive maintenance, thus lowering overall operational costs. Furthermore, expanding applications beyond traditional uses to areas like food safety and environmental research could open new market avenues. The nature of the market is competitive but fragmented, with a mix of established players and emerging companies. Strategic partnerships, mergers, and acquisitions are viable strategies to gain a competitive edge. The market demands ongoing research in biosafety, notably in optimizing airflow technology and user ergonomics, to cater to evolving user needs and regulatory standards while ensuring user safety and product efficacy.

Understanding Market Dynamics in the Biological Safety Cabinet Market

The Biological Safety Cabinet Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Favorable regulations driving the use of biological safety cabinets in the healthcare industry
    • Increased risk of pandemics and communicable diseases
    • Rapid growth in the number of biologics
  • Market Restraints
    • Alternative containment cabinet
  • Market Opportunities
    • Increasing number of R&D activities in biopharmaceutical and pharmaceutical companies
    • Rapid growth in the number of biologics increased investment in healthcare infrastructure in growing economies
  • Market Challenges
    • Development of low cost high quality biological safety cabinets

Exploring Porter’s Five Forces for the Biological Safety Cabinet Market

Porter’s Five Forces framework further strengthens the insights of the Biological Safety Cabinet Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Biological Safety Cabinet Market

External macro-environmental factors deeply influence the performance of the Biological Safety Cabinet Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Biological Safety Cabinet Market

The Biological Safety Cabinet Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Biological Safety Cabinet Market

The Biological Safety Cabinet Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Biological Safety Cabinet Market

The Biological Safety Cabinet Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biological Safety Cabinet Market, highlighting leading vendors and their innovative profiles. These include Air Science USA LLC by PyroGenesis Canada Inc., Alpha Linear, Berner International GmbH, Biobase Biodusty (Shandong), Co., Ltd., Esco Micro Pte. Ltd., EuroClone S.p.A., Flow Sciences, Inc., Germfree Laboratories, Inc., Haier Biomedical, Kewaunee Scientific Corporation, Labconco Corporation, Stericox India Private Limited, The Baker Company, Thermo Fisher Scientific Inc., and TopAir Systems Inc..

Market Segmentation & Coverage

This research report categorizes the Biological Safety Cabinet Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Class I
    • Class II
      • Class II Type A
      • Class II Type B
    • Class III
  • End User
    • Academic & Research Organizations
    • Diagnostics & Testing Laboratories
    • Pharmaceutical & Biopharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Favorable regulations driving the use of biological safety cabinets in the healthcare industry
5.1.1.2. Increased risk of pandemics and communicable diseases
5.1.1.3. Rapid growth in the number of biologics
5.1.2. Restraints
5.1.2.1. Alternative containment cabinet
5.1.3. Opportunities
5.1.3.1. Increasing number of R&D activities in biopharmaceutical and pharmaceutical companies
5.1.3.2. Rapid growth in the number of biologics increased investment in healthcare infrastructure in growing economies
5.1.4. Challenges
5.1.4.1. Development of low cost high quality biological safety cabinets
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Biological Safety Cabinet Market, by Type
6.1. Introduction
6.2. Class I
6.3. Class II
6.3.1. Class II Type A
6.3.2. Class II Type B
6.4. Class III
7. Biological Safety Cabinet Market, by End User
7.1. Introduction
7.2. Academic & Research Organizations
7.3. Diagnostics & Testing Laboratories
7.4. Pharmaceutical & Biopharmaceutical Companies
8. Americas Biological Safety Cabinet Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Biological Safety Cabinet Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Biological Safety Cabinet Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. BIOLOGICAL SAFETY CABINET MARKET RESEARCH PROCESS
FIGURE 2. BIOLOGICAL SAFETY CABINET MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. BIOLOGICAL SAFETY CABINET MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. BIOLOGICAL SAFETY CABINET MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. BIOLOGICAL SAFETY CABINET MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BIOLOGICAL SAFETY CABINET MARKET DYNAMICS
TABLE 7. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS I, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II TYPE A, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II TYPE B, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS III, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY ACADEMIC & RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY DIAGNOSTICS & TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 30. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 33. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 47. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 50. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 56. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. THAILAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. THAILAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 74. THAILAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. DENMARK BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. DENMARK BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 84. DENMARK BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. EGYPT BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. EGYPT BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 87. EGYPT BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. FINLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. FINLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 90. FINLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 93. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 96. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 102. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. NORWAY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. NORWAY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 111. NORWAY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. POLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. POLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 114. POLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. QATAR BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. QATAR BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 117. QATAR BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 129. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. TURKEY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. TURKEY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 138. TURKEY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. BIOLOGICAL SAFETY CABINET MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. BIOLOGICAL SAFETY CABINET MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Biological Safety Cabinet market, which are profiled in this report, include:
  • Air Science USA LLC by PyroGenesis Canada Inc.
  • Alpha Linear
  • Berner International GmbH
  • Biobase Biodusty (Shandong), Co., Ltd.
  • Esco Micro Pte. Ltd.
  • EuroClone S.p.A.
  • Flow Sciences, Inc.
  • Germfree Laboratories, Inc.
  • Haier Biomedical
  • Kewaunee Scientific Corporation
  • Labconco Corporation
  • Stericox India Private Limited
  • The Baker Company
  • Thermo Fisher Scientific Inc.
  • TopAir Systems Inc.

Methodology

Loading
LOADING...

Table Information